CFTR and cystic fibrosis: As reported by Molinski et al. (2017), PTI amplifier enhanced correction achieved with VX-809 and VX-770 treatment in CF cells and tissues from patients with rare CFTR mutations (ΔI1234_R1239-CFTR).